In a busy reporting day for biotechs, Orthocell reports promising results of a follow-up study of its nerve repair device Remplir.

These ASX mining juniors could be in the cross-hairs as 2025's next takeover targets according to our expert panel.

Ausgold is on the home straight to deliver the key definitive feasibility study for its Katanning gold project in WA’s Great ...

Military metals tungsten, tin, beryllium, rare earths and antimony are on investors' radars as war rages in the Middle East.

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

The ASX finished 0.15pc lower after a subdued day of trading. Investors are keeping to the sidelines as the Iran-Israel ...

In this episode, host Tylah Tully unpacks EZZ Life Science (ASX:EZZ) latest news. They have o fficially entered one of the world’s largest markets for health supplements, with the launch of its new ...

A comfortable retirement is more within reach for younger workers, and cost of essentials is easing for seniors. Here are the latest figures.

The ASX moves further into the afternoon in a flattish state. Iron ore has dipped, the Fed has flagged inflation and WiseTech has slid.

ASX slips 0.16pc as tech and materials sectors lag. Amplia Therapeutics reports a second complete response in its pancreatic cancer trial.

Lithium Universe has executed a binding agreement to acquire the global rights to patented photovoltaic solar panel recycling ...